trending Market Intelligence /marketintelligence/en/news-insights/trending/ctAcUOJEMIDn0NjC3oKDHg2 content esgSubNav
In This List

Assembly Biosciences appoints director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Assembly Biosciences appoints director

Assembly Biosciences Inc. increased the size of its board to eight members with the appointment of Sue Mahony as a director.

Mahony is president of Lilly Oncology, a senior vice president at Eli Lilly and Co. and a member of the company's executive committee.